[EN] 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES<br/>[FR] DERIVES DE 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE RENINE DANS LE TRAITEMENT DE L'HYPERTENSION, DE MALADIES CARDIOVASCULAIRES OU RENALES
申请人:ACTELION PHARMACEUTICALS LTD
公开号:WO2003093267A1
公开(公告)日:2003-11-13
The invention relates to novel 3,9-diazabicyclo[3.3.1]nonene derivatives of formula (I) and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors or renin.
Penem derivatives and antimicrobial agent containing the same
申请人:Ishiguro Masaji
公开号:US20050004092A1
公开(公告)日:2005-01-06
A penem derivative represented by the following formula (I):
wherein R
1
represents a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted alkylthio group, a substituted or unsubstituted alkenylthio group, a substituted or unsubstituted aralkylthio group, a substituted or unsubstituted arylthio group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted heterocyclic thio group, a substituted or unsubstituted acylthio group, a mercapto group or a hydrogen atom, and R
2
represents a hydrogen atom or a carboxyl-protecting group; or a pharmacologically acceptable salt thereof.
The compound (I) exhibits strong antibacterial activities, and especially, shows strong activities against MRSA. It is therefore useful not only as a general antibacterial agent but also as an antibacterial agent for MRSA against which no general antibacterial agents are recognized to be-effective.
Nucleic acid sequences containing unmethylated CpG dinucleotides that modulate an immune response including stimulating a Th1 pattern of immune activation, cytokine production, NK lytic activity, and B cell proliferation are disclosed. The sequences are also useful as synthetic adjuvant.
本研究公开了含有未甲基化 CpG 二核苷酸的核酸序列,这些核酸序列可调节免疫反应,包括刺激 Th1 型免疫激活、细胞因子产生、NK 吞噬活性和 B 细胞增殖。这些序列还可用作合成佐剂。
Use of unmethylated CpG oligonucleotides for the treatment of allergy
申请人:UNIVERSITY OF IOWA RESEARCH FOUNDATION
公开号:EP2322615A1
公开(公告)日:2011-05-18
An immuostimulatory nucleic acid containing an unmethylated CpG dinucleotide for use in a method of treating or preventing an allergy in a subject, wherein an effective dose of the immunostimulatory nucleic acid alone is to be administered to the subject.
An isolated immunostimulatory oligonucleotide comprising two or more unmethylated CpG dinucleotides, and having a sequence including the following formula:
5'N1X1X2CGTTN23'
wherein the immunostimulatory oligonucleotide includes a modified backbone, at least one nucleotide separates consecutive CpGs, X1X2 is GpT or ApT, N1 is any nucleotide that includes a 5' TC or TG, N1 + N2 is from 0-26 bases, and the immunostimulatory oligonucleotide is from 8-30 bases in length and begins with TC or TG at the 5' end, with the proviso that neither N1 nor N2 contains a CCGG quadmer or more than one CCG or CGG trimer.